Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Companion Diagnostics Market to Register Immense Growth at a CAGR of ~12% by 2032 | DelveInsight

prnewswire.com
AGNC Agilent Technologies is listed as a key company in the companion diagnostics market, which is projected to grow significantly. The article does not provide specific sentiment for Agilent but includes it in a list of market players. ABT Abbott Laboratories is mentioned as a key player in the companion diagnostics market, which is expected to experience substantial growth. The article does not offer specific sentiment towards Abbott but lists it among industry leaders. ILMN Illumina, Inc. is listed as a key company in the companion diagnostics market, which is projected to grow substantially. The article does not provide specific sentiment for Illumina but includes it in a list of market players. TMO Thermo Fisher Scientific Inc. is mentioned as a key player in the companion diagnostics market, which is expected to experience significant growth. The article does not offer specific sentiment towards Thermo Fisher but lists it among industry leaders. NVDA NVIDIA Corporation is listed as a key company in the AI in Cancer Diagnostics market, which is part of the broader diagnostics landscape discussed. The article does not provide specific sentiment for NVIDIA but includes it in a list of market players. IBM IBM Corporation is listed as a key company in the AI in Cancer Diagnostics market. The article does not provide specific sentiment for IBM but includes it in a list of market players within the AI diagnostics sector. EXAS Exact Sciences Corporation is mentioned in the context of the Molecular Diagnostics Market, which is related to the companion diagnostics market. The article does not provide specific sentiment for Exact Sciences but lists it among other market players. LH Laboratory Corporation of America Holdings is listed as a key company in the companion diagnostics market. The article does not provide specific sentiment for Labcorp but includes it in a list of market players. INV Invitae Corporation is listed as a key company in the companion diagnostics market. The article does not provide specific sentiment for Invitae but includes it in a list of market players.

Global Companion Diagnostics Market to Register Immense Growth at a CAGR of ~12% by 2032 | DelveInsight The growth of the companion diagnostics market is largely driven by the sharp worldwide rise in cancer incidence. Increasing awareness of precision medicine among patients, along with manufacturers' expanding efforts to advance precision-based treatments, has further strengthened the demand for companion diagnostics. In addition, intensified R&D aimed at creating companion tests for non-cancer conditions, together with a surge in product approvals and new launches, are expected to significantly propel the global companion diagnostics market throughout the forecast period (2025–2032).

LAS VEGAS, March 5, 2026 /PRNewswire/ -- DelveInsight's Companion Diagnostics Market Insights report provides the current and forecast market analysis, individual leading companion diagnostics companies' market shares, challenges, companion diagnostics market drivers, barriers, trends, and key companion diagnostics companies in the market.

Companion Diagnostics Market Summary

To read more about the latest highlights related to the companion diagnostics market, get a snapshot of the key highlights @ https://www.delveinsight.com/sample-request/companion-diagnostics-market?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr

Key Factors Contributing to the Rise in Growth of the Companion Diagnostics Market

Regional Companion Diagnostics Market Insights

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Get a sneak peek at the companion diagnostics market dynamics @ Companion Diagnostics Market Trends

Recent Developmental Activities in the Companion Diagnostics Market

What are Companion Diagnostics?

Companion diagnostics are specialized medical tests designed to identify whether a particular patient is likely to benefit from a specific drug or therapy. By analyzing biomarkers, such as genetic mutations, protein levels, or other molecular indicators, these tests help determine how an individual's body will respond to targeted treatments. This allows clinicians to personalize therapy, select the most effective medication, and avoid treatments that may be ineffective or cause unnecessary side effects. As a key component of precision medicine, companion diagnostics improve treatment outcomes by ensuring that the right patient receives the right therapy at the right time.

Companion Diagnostics Market Report Metrics

Details

Coverage

Global

Study Period

2022–2032

Companion Diagnostics Market CAGR

~12%

Companion Diagnostics Market Size by 2032

~USD 12 Billion

Key Companion Diagnostics Companies

Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Myriad Genetics, Inc., Abbott Laboratories, QIAGEN, BIOMÉRIEUX, Guardant Health Inc., Illumina, Inc., Pillar Biosciences, Inc., Leica Biosystems, Thermo Fisher Scientific Inc., Almac Group, NeoGenomics Laboratories, Invitae Corporation, 3D Medicines Corporation, ASURAGEN, INC. (Biotechne), Invivoscribe, Inc., Amoy Diagnostics Co., Ltd., Laboratory Corporation of America® Holdings, SAGA Diagnostics, and others

Companion Diagnostics Market Assessment

Which MedTech key players in the companion diagnostics market are set to emerge as the trendsetter explore @ Companion Diagnostics Market Analysis

Table of Contents

1

Companion Diagnostics Market Report Introduction

2

Companion Diagnostics Market Executive Summary

3

Competitive Landscape

4

Regulatory Analysis

5

Companion Diagnostics Market Key Factors Analysis

6

Companion Diagnostics Market Porter's Five Forces Analysis

7

Companion Diagnostics Market Layout

8

Companion Diagnostics Market Company and Product Profiles

9

KOL Views

10

Project Approach

11

About DelveInsight

12

Disclaimer & Contact Us

Interested in knowing the companion diagnostics market share by 2032? Click to get a snapshot of the Companion Diagnostics Market Size

Related Reports

Molecular Diagnostics Market

Molecular Diagnostics Market Insights, Competitive Landscape and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key molecular diagnostics companies, including Hoffmann-La Roche Ltd., Hologic, Inc., bioMérieux SA, Abbott, QIAGEN, BD, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Danaher, Myriad Genetics, Inc., Agilent Technologies Inc., Illumina Inc., DiaSorin Inc., MDxHealth, Genetic Signatures, Biocartis, Exact Sciences Corporation, Amoy Diagnostics Co. Ltd., Molbio Diagnostics Pvt. Ltd., Savyon Diagnostics, and others.

AI in Medical Diagnostics Market

AI in Medical Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key AI in medical diagnostics companies, including GE HealthCare, Aidoc, Qure.ai, Siemens Healthineers, PathAI, Ibex, Owkin, Inc., Imagen Technologies, Aiforia, RADLogics, Tecomet Inc., Prenosis, Inc., Riverain Technologies, Envisionit Deep AI (Pty) Ltd., Deep Bio, Inc., and others.

AI in Diagnostics Market

AI in Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key AI in diagnostics companies, including Aidoc, Owkin, Inc., Siemens Healthineers, PathAI, Ibex, Owkin, Inc., Imagen Technologies, Aiforia, RADLogics, Terarecon, Inc., Prenosis, Inc., Ibex, Google LLC, GE HealthCare, DreaMed, Riverain Technologies, Terarecon, Inc., Aiforia, RADLogics, and others.

AI in Cancer Diagnostics Market

AI in Cancer Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key AI in cancer diagnostics companies, including iCAD, Inc., ibex-ai, Roche Diagnostics, Kheiron Medical Technologies Limited, MVision AI Inc., Siemens Healthineers AG, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., IBM Corporation, Azra AI, ConcertAI, PathAI, Median Technologies, Paige AI Inc., Therapixel, Flatiron, Freenome Holdings Inc., Onc.AI, Sonrai Analytics, and others.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Contact Us

Shruti Thakur

[email protected]

+14699457679

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

SOURCE DelveInsight Business Research, LLP